39 results on '"Yoon, Janet"'
Search Results
2. The Discreet Transient
3. Preclinical characterization of pretargeted radioimmunotherapy (PRIT) with GD2-SADA, a self-assembling and disassembling bispecific fusion protein.
4. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease.
5. Underreporting of SMARCB1 Alteration by Clinical Sequencing: Integrative Patho-Genomic Analysis Captured SMARCB1/INI-1 Deficiency In A Vulvar Yolk Sac Tumor
6. Unusual Spinal Cord Tumor in A 16‐Month‐Old Child
7. A diffuse intrinsic pontine glioma in a neonate diagnosed by MRI
8. The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
9. Cardiovascular toxicities with pediatric tyrosine kinase inhibitor therapy: An analysis of adverse events reported to the Food and Drug Administration
10. Diagnostic challenges of bHCG interpretation following gonadectomy in a patient with Swyer syndrome
11. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
12. Cardiovascular toxicities with pediatric tyrosine kinase inhibitor therapy: An analysis of adverse events reported to the Food and Drug Administration.
13. Novel PTCH1 Mutation in a Young Child With Gorlin Syndrome and Medulloblastoma
14. Clinical isolated syndrome mimicking focal brainstem glioma in a child
15. Ring-enhancing pontine lesion in a young boy
16. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression
17. LGG-53. PNOC001 (NCT01734512): A PHASE II STUDY OF EVEROLIMUS FOR RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMAS (pLGG)
18. HGG-01. ENTRECTINIB IN RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS: UPDATED DATA IN CHILDREN AND ADOLESCENTS
19. DDRE-12. PNOC001 (NCT01734512): A PHASE II STUDY OF EVEROLIMUS FOR RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMAS (pLGG)
20. Can a pain management and palliative care curriculum improve the opioid prescribing practices of medical residents?
21. Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell lines
22. Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors.
23. PDCT-13. ENTRECTINIB IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS
24. Treatment of Infantile Choriocarcinoma of the Liver
25. Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.
26. Transcatheter arterial embolization as palliation in metastatic hepatocellular carcinoma
27. 391. Evaluation of Second-Generation Triazoles in the Treatment of Refractory Coccidioidomycosis
28. Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors.
29. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease
30. NovelPTCH1Mutation in a Young Child With Gorlin Syndrome and Medulloblastoma
31. Atypical Teratoid Rhabdoid Tumor in a Teenager with Unusual Infiltration Into the Jugular Foramen
32. Secondary Hemophagocytic Lymphohistiocytosis in a Patient With Favorable Histology Wilms Tumor
33. Phase 1 trial of GD2-SADA: 177 Lu-DOTA drug complex in patients with recurrent or refractory metastatic solid tumors known to express GD2 including small cell lung cancer (SCLC), sarcoma, and malignant melanoma.
34. A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas.
35. Glioblastoma Multiforme Arising From Dysembryoplastic Neuroepithelial Tumor in a Child in the Absence of Therapy
36. Anti‐tumor activity of the HSP90 inhibitor SNX‐2112 in pediatric cancer cell lines
37. A Novel Mutation in a Fijian Boy With Shwachman-Diamond Syndrome
38. Underground Factory.
39. Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1 /INI-1 deficiency in a vulvar yolk sac tumor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.